In 31 of the 60 SCLC cases (51.60%), the three traditional neuroendocrine tumor markers, namely, CD56, Syn, and CgA, were not fully expressed (i.e., they were not simultaneously positive). This evidence concerns the gene CGA and small cell lung carcinoma.